Isai Gallegos Gomez, Melissa Anahí Chan Verdugo, Jennifer Aída Ortega Romero, Daniela Denisse Torreros Lara, Rodrigo García González, Carmen Sabrina Campaña Medina, Ariadna Padilla, Abel Gallegos Aguilar, Eotoniel Sanchez Romero
{"title":"弥漫大 B 细胞淋巴瘤中枢神经系统复发的流行率：全面回顾","authors":"Isai Gallegos Gomez, Melissa Anahí Chan Verdugo, Jennifer Aída Ortega Romero, Daniela Denisse Torreros Lara, Rodrigo García González, Carmen Sabrina Campaña Medina, Ariadna Padilla, Abel Gallegos Aguilar, Eotoniel Sanchez Romero","doi":"10.47191/ijmscrs/v4-i03-31","DOIUrl":null,"url":null,"abstract":"Central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) is a rare but serious complication associated with poor outcomes. The prevalence of CNS relapse in DLBCL varies widely in the literature, ranging from 1% to 30%, depending on several risk factors and diagnostic methods. This article provides a comprehensive review of the current literature on the prevalence of CNS relapse in DLBCL, focusing on risk factors, diagnostic approaches, and treatment strategies. Understanding the epidemiology and clinical characteristics of CNS relapse in DLBCL is crucial for the development of effective preventive and therapeutic strategies.","PeriodicalId":335261,"journal":{"name":"International Journal Of Medical Science And Clinical Research Studies","volume":"61 33","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma: A Comprehensive Review\",\"authors\":\"Isai Gallegos Gomez, Melissa Anahí Chan Verdugo, Jennifer Aída Ortega Romero, Daniela Denisse Torreros Lara, Rodrigo García González, Carmen Sabrina Campaña Medina, Ariadna Padilla, Abel Gallegos Aguilar, Eotoniel Sanchez Romero\",\"doi\":\"10.47191/ijmscrs/v4-i03-31\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) is a rare but serious complication associated with poor outcomes. The prevalence of CNS relapse in DLBCL varies widely in the literature, ranging from 1% to 30%, depending on several risk factors and diagnostic methods. This article provides a comprehensive review of the current literature on the prevalence of CNS relapse in DLBCL, focusing on risk factors, diagnostic approaches, and treatment strategies. Understanding the epidemiology and clinical characteristics of CNS relapse in DLBCL is crucial for the development of effective preventive and therapeutic strategies.\",\"PeriodicalId\":335261,\"journal\":{\"name\":\"International Journal Of Medical Science And Clinical Research Studies\",\"volume\":\"61 33\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal Of Medical Science And Clinical Research Studies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47191/ijmscrs/v4-i03-31\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal Of Medical Science And Clinical Research Studies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47191/ijmscrs/v4-i03-31","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
弥漫大 B 细胞淋巴瘤（DLBCL）的中枢神经系统（CNS）复发是一种罕见但严重的并发症，且预后不佳。DLBCL的中枢神经系统复发率在文献中差异很大，从1%到30%不等，取决于多种风险因素和诊断方法。本文全面综述了目前关于DLBCL中枢神经系统复发率的文献，重点关注风险因素、诊断方法和治疗策略。了解DLBCL中枢神经系统复发的流行病学和临床特征对于制定有效的预防和治疗策略至关重要。
Prevalence of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma: A Comprehensive Review
Central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) is a rare but serious complication associated with poor outcomes. The prevalence of CNS relapse in DLBCL varies widely in the literature, ranging from 1% to 30%, depending on several risk factors and diagnostic methods. This article provides a comprehensive review of the current literature on the prevalence of CNS relapse in DLBCL, focusing on risk factors, diagnostic approaches, and treatment strategies. Understanding the epidemiology and clinical characteristics of CNS relapse in DLBCL is crucial for the development of effective preventive and therapeutic strategies.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
